[Role of the thymus in the physiopathology and in the prevention of type 1 diabetes].
There is now accumulating experimental evidence that, much more than a breakdown of peripheral immunological self-tolerance, the development of the diabetogenic autoimmune response (in type 1 diabetes) first results from a thymus dysfunction in the establishment of central beta-cell self-tolerance. Based on the homology between dominant thymic self-antigens and peripheral autoantigens, on the one hand, and the difference between the immune responses elicited by these antigens (respectively, tolerance vs immunity), a novel strategy is proposed for the development of a "negative" self-vaccine able to (re)install the state of immune self-tolerance to pancreatic islet beta cells and prevent type 1 diabetes.